SODIUM PENTOBARBITAL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Sodium Pentobarbital, and when can generic versions of Sodium Pentobarbital launch?
Sodium Pentobarbital is a drug marketed by Anabolic, Elkins Sinn, Everylife, Halsey, Ivax Sub Teva Pharms, Parke Davis, Perrigo, Purepac Pharm, Valeant Pharm Intl, Watson Labs, Wyeth Ayerst, and Nexgen Pharma Inc. and is included in thirteen NDAs.
The generic ingredient in SODIUM PENTOBARBITAL is pentobarbital sodium. There are two drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the pentobarbital sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sodium Pentobarbital
A generic version of SODIUM PENTOBARBITAL was approved as pentobarbital sodium by SAGENT PHARMS INC on May 23rd, 2016.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SODIUM PENTOBARBITAL?
- What are the global sales for SODIUM PENTOBARBITAL?
- What is Average Wholesale Price for SODIUM PENTOBARBITAL?
Summary for SODIUM PENTOBARBITAL
US Patents: | 0 |
Applicants: | 12 |
NDAs: | 13 |
Raw Ingredient (Bulk) Api Vendors: | 29 |
Patent Applications: | 3,672 |
DailyMed Link: | SODIUM PENTOBARBITAL at DailyMed |
US Patents and Regulatory Information for SODIUM PENTOBARBITAL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anabolic | SODIUM PENTOBARBITAL | pentobarbital sodium | CAPSULE;ORAL | 084590-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Parke Davis | SODIUM PENTOBARBITAL | pentobarbital sodium | CAPSULE;ORAL | 084156-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Halsey | SODIUM PENTOBARBITAL | pentobarbital sodium | CAPSULE;ORAL | 084677-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Wyeth Ayerst | SODIUM PENTOBARBITAL | pentobarbital sodium | CAPSULE;ORAL | 083239-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Perrigo | SODIUM PENTOBARBITAL | pentobarbital sodium | CAPSULE;ORAL | 084560-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Nexgen Pharma Inc | SODIUM PENTOBARBITAL | pentobarbital sodium | TABLET;ORAL | 084238-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Elkins Sinn | SODIUM PENTOBARBITAL | pentobarbital sodium | CAPSULE;ORAL | 083368-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |